Three Binding Conformations of BIO124 in the Pocket of the PICK1 PDZ Domain

Cells. 2022 Aug 7;11(15):2451. doi: 10.3390/cells11152451.

Abstract

The PDZ family has drawn attention as possible drug targets because of the domains' wide ranges of function and highly conserved binding pockets. The PICK1 PDZ domain has been proposed as a possible drug target because the interactions between the PICK1 PDZ domain and the GluA2 subunit of the AMPA receptor have been shown to progress neurodegenerative diseases. BIO124 has been identified as a sub µM inhibitor of the PICK1-GluA2 interaction. Here, we use all-atom molecular dynamics simulations to reveal the atomic-level interaction pattern between the PICK1 PDZ domain and BIO124. Our simulations reveal three unique binding conformations of BIO124 in the PICK1 PDZ binding pocket, referred to here as state 0, state 1, and state 2. Each conformation is defined by a unique hydrogen bonding network and a unique pattern of hydrophobic interactions between BIO124 and the PICK1 PDZ domain. Interestingly, each conformation of BIO124 results in different dynamic changes to the PICK1 PDZ domain. Unlike states 1 and 2, state 0 induces dynamic coupling between BIO124 and the αA helix. Notably, this dynamic coupling with the αA helix is similar to what has been observed in other PDZ-ligand complexes. Our analysis indicates that the interactions formed between BIO124 and I35 may be the key to inducing dynamic coupling with the αA helix. Lastly, we suspect that the conformational shifts observed in our simulations may affect the stability and thus the overall effectiveness of BIO124. We propose that a physically larger inhibitor may be necessary to ensure sufficient interactions that permit stable binding between a drug and the PICK1 PDZ domain.

Keywords: BIO124; PDZ domain; PICK1; dynamic allosterism.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Carrier Proteins* / metabolism
  • Molecular Conformation
  • Nuclear Proteins / metabolism
  • PDZ Domains*
  • Receptors, AMPA / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Nuclear Proteins
  • Receptors, AMPA

Grants and funding

This research was funded by the National Science Foundation Graduate Research Fellow- ship Program (Grant No. DGE-1939267) and the National Science Foundation (Grant No. 2137558). This work was also supported by the Substance Use Disorders Grand Challenge Pilot Research Award, the Research Allocations Committee (RAC) Award, and the University of New Mexico Office of the Vice President for Research WeR1 Faculty Success Program. We also acknowledge the Centre of Informatics-Tricity Academic Supercomputer & network (CI TASK) in Gdansk, Poland, for the availability of high-performance computing resources.